prostate cancer

The advance could lead to safer, more effective T cell therapies for prostate cancer and other solid tumors.

Shorter courses of androgen deprivation therapy could reduce risks while still effectively controlling cancer.

Bruingenuity is on vivid display in myriad inventions that save and improve lives every day. Bonus: gourmet slime!

Here are just some of the lifesaving therapies that were developed by or stemmed from research at UCLA.

The clinical trial demonstrates that combining genetically engineered T cells and stem cells can produce cancer-fighting immune cells in humans.

Researchers found that very small elevations in two biomarkers are strong and independent predictors of overall cancer risk.

The algorithm unlocks the full potential of proteogenomics by overcoming a key challenge in linking genetic mutations to protein-level changes.

Jung, who will deliver UCLA’s 130th Faculty Research Lecture, explains how he developed cancer-fighting drugs.

UCLA researchers looked at how using MRI, MRI-guided biopsies and focal therapy can help men with prostate cancer remain on active surveillance.

Shorter, higher-dose-per-day radiation courses should be the standard regimen for men with localized disease.

Chemotherapy can affect appetite and digestion, so preparation and flexibility are key.

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

It’s here. It’s going to change life as we know it. Are you ready? Are you sure?

The ‘nomogram’ opens the door to improved personalized treatments, a UCLA-led study shows.

Research brief: Improving imaging processes will lead to more successful treatments and help reduce morbidity in men with the disease.

The new method should become the standard of care, say researchers from both universities who validated its effectiveness.

Research brief: Findings from a UCLA study indicate some men may not require the intensive treatment they have traditionally received.

The funds will help advance work in diagnosis, prognosis and treatment of the disease

The finding suggests that predicting how a person’s cancer will evolve may lie in their inherited genetic material.

The study results have the potential to establish a new standard for using this method to actively monitor prostate cancer.

The observation helps explain why, as people age, the prostate tends to grow, leading to an increased risk for cancer and other conditions.

Research brief: The study recommends that the new procedure should become the standard of care.

50% of treatments could have been avoided using the new tool, a UCLA-led study finds.

Combining biopsy strategies allowed doctors to find up to 33% more cancers.

Research Brief: Researchers compared the system’s results with readings by UCLA doctors who had more than 10 years of experience.